YOUR BUSINESS AUTHORITY
Springfield, MO
Pfizer Inc. announced it would buy Array Biopharma for $16.4 billion in cash.
Array makes approved treatments for skin cancer.
"(The acquisition) sets the stage to create a potentially industry-leading franchise for colorectal cancer alongside Pfizer's existing expertise in breast and prostate cancers," Pfizer CEO Albert Bourla said.
Read more from Reuters.
Project work in Springfield corridor will continue into 2031.